Global Life Science Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Managing
  • Professionals
  • 2
Professionals
  • Investments
  • 57
  • Portfolio
  • 2
  • Exits
  • 31
Exits

Global Life Science Ventures General Information

Description

Global Life Science Ventures is a venture capital firm focusing on the life science sector. The firm is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The firm was founded in 1996 and is based in Munich, Germany.

Contact Information

Year Founded
1996
Investor Status
Fully Invested, No Longer Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Tal 26
  • 80331 Munich
  • Germany
+49 089 0000000

Global Life Science Ventures Investments (57)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Nabriva Therapeutics 07-Apr-2015 Later Stage VC 00000 Drug Discovery Generating Revenue/Not Profitable 00000 00000000 00.0
000000 00000000000 31-Dec-2014 0000 0000 Drug Discovery Generating Revenue/Not Profitable
000000 00000000000 26-Nov-2014 00000 00000 00.000 Drug Discovery Generating Revenue/Not Profitable 0000 0ü0000 00.0
00000000 000000 20-Jun-2012 00000 00000 0000 Biotechnology Generating Revenue 000000 000000000 00.0
000000 000000 03-May-2012 00000 00000 000.00 Surgical Devices Generating Revenue/Not Profitable
0000000 0000000000 01-Mar-2012 00000000000 Drug Discovery Generating Revenue/Not Profitable 00000 00000000 00.0
0000000 0000000000 01-Jul-2011 00000000000 Drug Discovery Generating Revenue/Not Profitable 00000 00000000 00.0
0000000 0000000000 01-Oct-2010 00000 00000 000.00 Drug Discovery Generating Revenue/Not Profitable 00000 00000000 00.0
Action Pharma 03-Jun-2010 Later Stage VC 00.000 Drug Discovery Generating Revenue
Horizon Therapeutics 17-May-2010 Early Stage VC 000.00 Pharmaceuticals Profitable
You’re viewing 10 of 57 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Global Life Science Ventures Exits (31)

Company Name Exit Date Exit Type Exit Size
Sequenom 07-Sep-2016 Merger/Acquisition 00000
0000000 0000000000 18-Sep-2015 000 000.00
00000000 000000 31-Aug-2014 000000000000000000 00000
000000 000000 17-Jun-2014 000 0000
0000000 0000000000 09-Jan-2014 0000000000: 000000
000000 0000000 01-Nov-2012 000 00 00000000
000000 000000 15-Jun-2012 000000000000000000 00000
000 000000 01-Apr-2012 00000000 000000 00
Horizon Therapeutics 28-Jul-2011 IPO 000.00
Spinal Cord Therapeutics 01-Jul-2011 Out of Business
You’re viewing 10 of 31 exits. Get the full list »

Global Life Science Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Global Life Science Ventures‘s full profile, request access.

Request a free trial

Global Life Science Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Global Life Science Ventures Team (7)

Name Title Deals Funds Boards Office
Hans Küpper Ph.D Partner 0 0 Munich, Germany
Peter Reinisch Ph.D Partner 0 0 Munich, Germany
You’re viewing 2 of 7 team members. Get the full list »